Arca
Skip to content
Tools
Tools

Bromfenac Ophthalmic Solution 0.09%

Recall D-0585-2016, part of FDA recall event 73072. See Mayne Pharma USA's company page.

Mayne Pharma Usa started this Class II drug recall on Jan 5, 2016 (voluntary: firm initiated); FDA lists it as terminated, terminated Jan 13, 2017.

  • Classification: Class II
  • Started: Jan 5, 2016
  • Status: Terminated

Why It Was Recalled

Class II

Lack of Assurance of Sterility: Failed preservative effectiveness test

Record

Product
Bromfenac Ophthalmic Solution 0.09%, a) 2.5 mL bottles (NDC 0378-7110-35) and b) 5 mL bottles (NDC 00378-7109-35), Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505
Quantity
a) 52034 bottles and b) 22074 bottles
Lots and codes
a) Lot numbers: 0378-7110-35 AD4819, Exp. Date: 08-2016; 0378-7110-35 AC7894, Exp. Date: 05-2016; 0378-7110-35 AD2527, Exp. Date: 06-2016; 0378-7110-35 AC6330, Exp. Date: 05-2016; 0378-7110-35 AC2330, Exp. Date: 04-2016 and b) Lot numbers: 0378-7109-35 AD4515, Exp. Date: 04-2016 and 0378-7109-35 AC2328, Exp. Date: 01-2016.
Distribution
Nationwide
Recalling firm
Mayne Pharma Usa, Greenville, NC, United States
How the firm notified
Letter
FDA classified
Jan 20, 2016

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.